Rhinitis, Allergic
Conditions
Brief summary
Allergic rhinitis is one of the most common inflammatory conditions of the upper airway mucosa, especially in the pediatric population with a prevalence of approximately 25%. It is among the most common chronic inflammatory diseases globally and is caused by IgE-mediated reactions to inhaled allergens, often co-occurring with asthma and causing severe burdens and disabilities worldwide. Allergic rhinitis can in fact seriously compromise the quality of life, significantly influencing school performance, social life and the quality of sleep. It is known that the most common symptoms characterizing allergic rhinitis (itching of the nose, sneezing, rhinorrhea and nasal/sinus obstruction) are partly overlapping with those due to a condition of deviation of the nasal septum and a recent study has shown how 87 % of patients with persistent allergic rhinitis are affected by at least 1 of the 7 types of nasal septum deformity. Deviation of the nasal septum is a very frequent anatomical disorder and is present in up to 48% of children and adolescents in the general population. The deviation narrows the affected nostril canal, reducing the flow of air that passes through the nostrils, predisposing to chronic mucosal inflammation with inflammatory infiltrate and in turn increasing the risk of developing chronic rhinitis and sinusitis. There are no data in the literature that correlate nasal septum deviation with an increased risk of developing allergic rhinitis. Given these premises, the ARHINASD (Allergic Rhinitis in pediatric topics with Nasal Septum Deviation) study was designed with the primary objective of evaluating the presence of allergic rhinitis in a sample of patients with and without deviation of the nasal septum.
Interventions
OTHERData collection
Data collection
Sponsors
Federico II University
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No
Inclusion criteria
* Caucasian ethnicity * both sexes * age between 6 and 14 years * written informed consent.
Exclusion criteria
* Non-Caucasian ethnicity * Age \<6 and \>14 years Concomitant presence of: * chronic diseases * malignancies * immunodeficiency * chronic infections * autoimmune diseases * chronic inflammatory intestinal diseases * celiac disease * genetic diseases * metabolic diseases * cystic fibrosis * chronic pulmonary diseases * malformations of the cardiovascular system * malformations of the respiratory system * malformations of the gastrointestinal system * neuropsychiatric disorders * neurological diseases * obesity * eosinophilic diseases * antibiotics use in the last 7 days * cortisone use in the last 7 days * antihistamines use in the last 7 days * trauma at nose level in the 3 years before the enrollment, * history of previous nose surgery, or previous major surgery procedures of gastrointestinal, cardiovascular, urinary or respiratory tract
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of allergic rhinitis | 12 months | Complete clinical and anamnestic evaluation and allergy screening test (Skin-Prick Test). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total IgE of nasal wash supernatant | 12 months | ELISA kit |
| Cytokines (IL-13, IL-9, IL-33, IL-5, INFγ, β-defensin, IL-17, TNFα) of nasal wash supernatant | 12 months | ELISA kit |
| Quality of life questionnaire | 12 months | Quality of life questionnaire (VAS) |
| Peak inspiratory nasal flow | 12 months | PNIF test |
| Nasal cytology | 12 months | Performed with the nasal scraping to obtain cells which are then stained with May-Grunwald and Giemsa staining and observed using an optical microscope |
Countries
Italy
Outcome results
None listed